MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

Search

Kala Pharmaceuticals Inc

Open

0.64 23.08

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.52

Max

0.65

Belangrijke statistieken

By Trading Economics

Dividenden

By Dow Jones

Volgende Winsten

30 mrt 2026

Kala Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 jan 2026, 18:44 UTC

Belangrijke Marktbewegers

Agenus Falls After $141 Million Zydus Deal Closes

15 jan 2026, 17:51 UTC

Belangrijke Marktbewegers

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15 jan 2026, 17:25 UTC

Belangrijke Marktbewegers

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15 jan 2026, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 jan 2026, 23:48 UTC

Marktinformatie

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15 jan 2026, 23:40 UTC

Marktinformatie

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15 jan 2026, 23:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

15 jan 2026, 23:11 UTC

Marktinformatie

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15 jan 2026, 23:01 UTC

Marktinformatie

New Zealand's Economy Enters An Upswing -- Market Talk

15 jan 2026, 22:56 UTC

Marktinformatie
Winsten

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15 jan 2026, 22:51 UTC

Marktinformatie

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15 jan 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15 jan 2026, 21:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

15 jan 2026, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Energy & Utilities Roundup: Market Talk

15 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

15 jan 2026, 21:27 UTC

Winsten

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15 jan 2026, 21:15 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Commodities Roundup: Market Talk

15 jan 2026, 21:11 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

15 jan 2026, 21:11 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15 jan 2026, 20:10 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15 jan 2026, 20:04 UTC

Winsten

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15 jan 2026, 20:03 UTC

Marktinformatie

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15 jan 2026, 19:26 UTC

Marktinformatie

Silver Closes at Fresh High -- Market Talk

15 jan 2026, 18:29 UTC

Belangrijke Marktbewegers

Agenus Falls After $141M Zydus Deal Closes

15 jan 2026, 18:20 UTC

Winsten

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15 jan 2026, 17:56 UTC

Marktinformatie
Winsten

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15 jan 2026, 17:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Auto & Transport Roundup: Market Talk

15 jan 2026, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

15 jan 2026, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

15 jan 2026, 17:02 UTC

Acquisities, Fusies, Overnames

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Peer Vergelijking

Prijswijziging

Kala Pharmaceuticals Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financieel

$

Over Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat